Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Effect of Aging on Tissues01:19

The Effect of Aging on Tissues

Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
Aging01:26

Aging

Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Competing programs shape cortical sensorimotor-association axis development.

Nature·2026
Same author

Evaluating the effectiveness of simvastatin in slowing the progression of disability in secondary progressive multiple sclerosis: a synopsis of MS-STAT2, a multicentre, randomised controlled, double-blind, phase 3 clinical trial.

Health technology assessment (Winchester, England)·2026
Same author

Myelin Repair as a Neuroprotective Strategy for Multiple Sclerosis: From Bench to Bedside.

Medicina (Kaunas, Lithuania)·2026
Same author

Disease-modifying treatment preferences and decision-making in a multiple sclerosis randomized and observational clinical trial (DELIVER-MS).

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same author

Predominance of Ferroptotic Cell Death Mechanisms in Substantia Nigra Neurodegeneration in Parkinson's Disease.

Annals of neurology·2026
Same author

Astrocyte-specific FoxF2 modulates immune and myelin repair: Evidence from multiple sclerosis lesions and an animal model.

Journal of neuroimmunology·2026

Related Experiment Video

Updated: May 12, 2026

An Ex vivo Model of an Oligodendrocyte-directed T-Cell Attack in Acute Brain Slices
06:36

An Ex vivo Model of an Oligodendrocyte-directed T-Cell Attack in Acute Brain Slices

Published on: February 5, 2015

6.9K

Accelerated Cellular Senescence in Progressive Multiple Sclerosis: A Histopathological Study.

Dimitrios Papadopoulos1,2,3, Roberta Magliozzi4,5, Sara Bandiera5

  • 1School of Medicine, European University, Nicosia, Cyprus.

Annals of Neurology
|February 1, 2025
PubMed
Summary
This summary is machine-generated.

Cellular senescence (CS) is present in progressive multiple sclerosis (P-MS) lesions and associated with faster disease progression. Identifying CS in P-MS offers new therapeutic targets for neurodegeneration.

More Related Videos

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines
09:46

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines

Published on: September 21, 2021

4.6K
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

11.4K

Related Experiment Videos

Last Updated: May 12, 2026

An Ex vivo Model of an Oligodendrocyte-directed T-Cell Attack in Acute Brain Slices
06:36

An Ex vivo Model of an Oligodendrocyte-directed T-Cell Attack in Acute Brain Slices

Published on: February 5, 2015

6.9K
Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines
09:46

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines

Published on: September 21, 2021

4.6K
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

11.4K

Area of Science:

  • Neuroscience
  • Immunology
  • Cell Biology

Background:

  • The neurodegenerative mechanisms underlying progressive multiple sclerosis (P-MS) disability remain incompletely understood.
  • Emerging evidence implicates cellular senescence (CS) in neurodegenerative conditions.
  • This study investigates the presence and pattern of CS in P-MS.

Purpose of the Study:

  • To investigate for evidence of cellular senescence (CS) in progressive multiple sclerosis (P-MS).
  • To determine the distribution and cellular origins of CS in P-MS lesions.
  • To correlate CS markers with disease progression and clinical outcomes.

Main Methods:

  • Utilized autopsy material from P-MS patients and healthy controls.
  • Assessed cellular senescence (CS) using markers 53BP1, p16, and lipofuscin in white matter lesions (WMLs), normal-appearing white matter (NAWM), and gray matter (NAGM).
  • Quantified senescence-associated secretory phenotype (SASP) factors in cerebrospinal fluid (CSF) and correlated with senescent cell markers.

Main Results:

  • Significantly increased p16+ and lipofuscin+ cells were found in P-MS white matter lesions (WMLs) and gray matter lesions (GMLs) compared to controls.
  • Cellular senescence (CS) was identified in neurons, astrocytes, oligodendrocytes, microglia, and macrophages within lesions.
  • Higher senescent cell counts in P-MS correlated with faster progression to wheelchair use and increased mortality.

Conclusions:

  • Cellular senescence (CS) is a prominent feature in actively demyelinating lesions in progressive multiple sclerosis (P-MS).
  • The burden of senescent cells in P-MS is linked to accelerated disease progression and poorer clinical outcomes.
  • These findings highlight CS as a potential therapeutic target for P-MS.